ID   HIOEC-B(a)P-TPA
AC   CVCL_C1LG
DR   Wikidata; Q114311623
RX   Patent=CN1730663A;
RX   PubMed=16685356;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E43 ! HIOEC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
RX   Patent=CN1730663A;
RA   Zhang Z.-Z., Pan H.-Y., Cao J., Pa T.-M., Zhou X.-J., Chen W.-T., Li J.,
RA   Zhang P., He R.-G.;
RT   "A kind of oral mucosa epithelial cell canceration model.";
RL   Patent number CN1730663A, 08-Feb-2006.
//
RX   PubMed=16685356;
RA   Pan H.-Y., Zhang Z.-Y., Zhou X.-J., Li J., Zhang P., Chen W.-T.;
RT   "The establishment of B(a)P and TPA transformed cell line and its
RT   biological characteristics.";
RL   Shanghai Kou Qiang Yi Xue 15:152-156(2006).
//